Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations
ConclusionsBy integrating T2D GWAS from multiple populations, we developed and validated a trans-ancestry PRS, and demonstrated its potential as a meaningful index of risk among diverse patients in clinical settings. Our efforts represent the first step towards the implementation of the T2D PRS into routine healthcare.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research
More News: African Health | Diabetes | Diabetes Type 2 | Electronic Medical Records (EMR) | Endocrinology | Environmental Health | Genetics | Study | Taiwan Health